<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>World Allergy Organization subcutaneous immunotherapy systemic reaction grading system</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">World Allergy Organization subcutaneous immunotherapy systemic reaction grading system</h1>
<div class="graphic"><div class="figure"><div class="ttl">World Allergy Organization subcutaneous immunotherapy systemic reaction grading system</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Grade 1</td> <td class="subtitle1">Grade 2</td> <td class="subtitle1">Grade 3</td> <td class="subtitle1">Grade 4</td> <td class="subtitle1">Grade 5</td> </tr> <tr class="divider_bottom"> <td> <p><strong><em>Symptom(s)/sign(s) of one organ system present*</em></strong></p> <p><strong>Cutaneous</strong></p> <p>Generalized pruritus, urticaria, flushing, or sensation of heat or warmth<sup>¶</sup></p> <p><strong>or</strong></p> <p>Angioedema (not laryngeal, tongue, or uvular)</p> <p><strong>or</strong></p> <p><strong>Upper respiratory</strong></p> <p>Rhinitis (eg, sneezing, rhinorrhea, nasal pruritus, and/or nasal congestion)</p> <p><strong>or</strong></p> <p>Throat-clearing (itchy throat)</p> <p><strong>or</strong></p> <p>Cough perceived to originate in the upper airway, not the lung, larynx, or trachea</p> <p><strong>or</strong></p> <p><strong>Conjunctival</strong></p> <p>Erythema, pruritus, or tearing </p> <p><strong>Other</strong></p> Nausea, metallic taste, or headache</td> <td> <p><strong><em>Symptom(s)/sign(s) of more than one organ system present</em></strong></p> <p><strong>or</strong></p> <p><strong>Lower respiratory</strong></p> <p>Asthma: Cough, wheezing, shortness of breath (eg, less than 40% PEF or FEV<sub>1</sub> drop, responding to an inhaled bronchodilator)</p> <p><strong>or</strong></p> <p><strong>Gastrointestinal</strong></p> <p>Abdominal cramps, vomiting, or diarrhea</p> <p><strong>or</strong></p> <p><strong>Other</strong></p> Uterine cramps</td> <td> <p><strong>Lower respiratory</strong></p> <p>Asthma (eg, 40% PEF or FEV<sub>1</sub> drop <strong>not</strong> responding to an inhaled bronchodilator)</p> <p><strong>or</strong></p> <p><strong>Upper respiratory</strong></p> Laryngeal, uvula, or tongue edema with or without stridor</td> <td> <p><strong>Lower or upper respiratory</strong></p> <p>Respiratory failure with or without loss of consciousness</p> <p><strong>or</strong></p> <p><strong>Cardiovascular</strong></p> Hypotension with or without loss of consciousness</td> <td>Death</td> </tr> <tr class="divider_bottom"> <td colspan="5">Patients may also have a feeling of impending doom, especially in grades 2, 3, or 4.<br/> <strong>NOTE:</strong> Children with anaphylaxis seldom convey a sense of impending doom, and their behavior changes may be a sign of anaphylaxis (eg, becoming very quiet or irritable and cranky).<br/> <strong>Scoring includes a suffix that denotes if and when epinephrine is or is not administered in relationship to onset of symptom(s)/sign(s) of the systemic reaction: a: ≤5 minutes; b: &gt;5 minutes to ≤10 minutes; c: &gt;10 to ≤20 minutes; d: &gt;20 minutes; z: epinephrine not administered.</strong><br/> The final grade of the reaction will not be determined until the event is over, regardless of the medication administered. The final report should include the first symptom(s)/sign(s) and the time of onset after the subcutaneous allergen immunotherapy injection<sup>Δ</sup> and a suffix reflecting if and when epinephrine was or was not administered (eg, Grade 2a; rhinitis: 10 minutes).</td> </tr> <tr class="divider_bottom"> <td colspan="5"> <p><strong>Final report:</strong></p> <p>Grade a to d or z___________</p> <p>First symptom(s)/sign(s)___________</p> Time of onset of first symptom___________</td> </tr> <tr> <td colspan="5"><strong>Comments:</strong><sup>◊</sup></td> </tr> </tbody></table></div><div class="graphic_footnotes">PEF: peak expiratory flow; FEV<sub>1</sub>: forced expiratory volume in one second.<br/>* Each grade is based on organ system involved and severity. Organ systems are defined as cutaneous, conjunctival, upper respiratory, lower respiratory, gastrointestinal, cardiovascular, and other. A reaction from a single organ system, such as cutaneous, conjunctival, or upper respiratory, but not asthma, gastrointestinal, or cardiovascular is classified as a grade 1. Symptom(s)/sign(s) from more than one organ system or asthma, gastrointestinal, or cardiovascular are classified as grades 2 or 3. Respiratory failure or hypotension with or without loss of consciousness define grade 4 and death grade 5. The grade is determined by the clinician's clinical judgment.<br/>¶ This constellation of symptoms may rapidly progress to a more severe reaction.<br/>Δ Symptoms occurring within the first minutes after the injection may be a sign of severe anaphylaxis. Mild symptoms may progress rapidly to severe anaphylaxis and death.<br/><font class="lozenge">◊</font> If signs or symptoms are not included in the table or the differentiation between a systemic reaction and vasovagal (vasodepressor) reaction, which may occur with any medical intervention, is difficult, please include comments, as appropriate.</div><div class="graphic_reference">Reproduced from: Cox L, Larenas-Linnemann D, Lockey RF, et al. Speaking the same language: The World Allergy Organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol 2010; 125:569. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 85944 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
